Campbell & Co Investment Adviser’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
TAM
SI
CPC
Campbell & Co Investment Adviser's NVS Position: Q2 2026 in Review
Campbell & Co Investment Adviser sold out of Novartis (NVS) in Q2 2026, closing a stake of 39,646 shares — an estimated $6.06M sold.
Campbell & Co Investment Adviser first reported a position in NVS in Q2 2013 and held it in 14 quarters. The position peaked at $9.69M in Q4 2024. 831 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Campbell & Co Investment Adviser reported no remaining Novartis position as of Q2 2026 after selling out during the quarter.
- Campbell & Co Investment Adviser sold 39,646 Novartis shares in Q2 2026, an estimated $6.06M.
- Campbell & Co Investment Adviser first reported a position in Novartis in Q2 2013 and held it in 14 quarters.
- Campbell & Co Investment Adviser's Novartis position peaked at $9.69M in Q4 2024.
- 831 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.